XRAY Quote, Financials, Valuation and Earnings

Biolase has a net margin of -47.51% compared to Dentsply Sirona's net margin of -13.16%. Dentsply Sirona's return on equity of -32.39% beat Biolase's return on equity of -21668.17%.

Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 31.77%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 22321.53%. Given that Biolase has higher upside potential than Dentsply Sirona, analysts believe Biolase is more attractive than Dentsply Sirona.

Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Biolase has a beta of 0.817, suggesting its less volatile than the S&P 500 by 18.311%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.18%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Biolase quarterly revenues of $10.9M. Dentsply Sirona's net income of -$430M is lower than Biolase's net income of -$1.4M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.82x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

Milestone Scientific has a net margin of -47.51% compared to Dentsply Sirona's net margin of -58.13%. Dentsply Sirona's return on equity of -32.39% beat Milestone Scientific's return on equity of -61.33%.

Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 31.77%. On the other hand Milestone Scientific has an analysts' consensus of -- which suggests that it could grow by 129.66%. Given that Milestone Scientific has higher upside potential than Dentsply Sirona, analysts believe Milestone Scientific is more attractive than Dentsply Sirona.

Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Milestone Scientific has a beta of 1.409, suggesting its more volatile than the S&P 500 by 40.929%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.18%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Milestone Scientific quarterly revenues of $2.5M. Dentsply Sirona's net income of -$430M is lower than Milestone Scientific's net income of -$1.5M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.82x versus 8.17x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Envista Holdings has a net margin of -47.51% compared to Dentsply Sirona's net margin of 0.18%. Dentsply Sirona's return on equity of -32.39% beat Envista Holdings's return on equity of -32.33%.

Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 31.77%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 28.13%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Envista Holdings has a beta of 1.326, suggesting its more volatile than the S&P 500 by 32.59%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.18%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Envista Holdings quarterly revenues of $652.9M. Dentsply Sirona's net income of -$430M is lower than Envista Holdings's net income of $1.2M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.82x versus 1.15x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Wellness Center USA has a net margin of -47.51% compared to Dentsply Sirona's net margin of --. Dentsply Sirona's return on equity of -32.39% beat Wellness Center USA's return on equity of --.

Dentsply Sirona has a consensus price target of $20.20, signalling upside risk potential of 31.77%. On the other hand Wellness Center USA has an analysts' consensus of -- which suggests that it could fall by --. Given that Dentsply Sirona has higher upside potential than Wellness Center USA, analysts believe Dentsply Sirona is more attractive than Wellness Center USA.

Dentsply Sirona has a beta of 0.976, which suggesting that the stock is 2.383% less volatile than S&P 500. In comparison Wellness Center USA has a beta of 1.978, suggesting its more volatile than the S&P 500 by 97.837%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.18%. Wellness Center USA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Wellness Center USA pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Wellness Center USA quarterly revenues of --. Dentsply Sirona's net income of -$430M is higher than Wellness Center USA's net income of --. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Wellness Center USA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.82x versus 0.03x for Wellness Center USA. Usually stocks with elevated PS ratios are considered overvalued.